Excellerate Bioscience Limited
10228159
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
30/06/2025
total exemption full
Next accounts due
31/03/2027
Confirmation statement
Last: 28/06/2025
Due 12/07/2026
Industry
Officers
director · Since 21/04/2017
FINANCE DIRECTOR
BRITISH · ENGLAND · Age 57
Also on 7 other boards
director · Since 25/05/2018
COMPANY DIRECTOR
BRITISH · ENGLAND · Age 57
Also on 3 other boards
director · Since 22/07/2020
DIRECTOR
BRITISH · ENGLAND · Age 54
Also on 2 other boards
Persons with Significant Control
Excellerate Bioscience Holdings Limited
Third Floor, Two Colton Square, Leicester, LE1 1QH
Reg: 12326225 · Companies House · Private Limited Company
Notified 14/02/2020
Former PSCs
Mr Steven John Charlton
Ceased 14/02/2020
Mr Viral Patel
Ceased 18/04/2017
Mr Viral Laxmiprasad Patel
Ceased 14/02/2020
Mr Sukhjinder Singh Chahal
Ceased 14/02/2020
CompanyRankvs 107+ SIC 72110 peers84
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2025
Net Worth
£2.8M
Balance sheet strength
Cash
£1.7M
Cash in the bank
Net Current Assets
£2.0M
Working capital
Current Assets
£2.5M
Current Liabilities
£522k
Fixed Assets
£796k
Debtors
£848k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 4.79 | +£846k |
| 2024 | 2.92 | +£383k |
| 2023 | 3.75 | +£632k |
| 2022 | 2.77 | +£336k |
| 2021 | 2.06 | +£282k |
| 2020 | 1.32 | -£240k |
| 2019 | 1.50 | +£254k |
| 2018 | 1.19 | — |
Derived from filed accounts. Not audited figures.